India's leading generic companies, such as Sun Pharma, Zydus Lifesciences, Lupin, MSN Lbs, Alkem Laboratories, Dr Reddy's Laboratories, Torrent Pharmaceuticals, Natco Pharma, and many others, are set to tap a massive revenue opportunity exceeding Rs 50,000 crore (approximately $6 billion) from India, select regulated markets, and emerging economies
Your lifestyle may be something to consider, too, when deciding between the two medications
Were proud to offer some of the most competitive pricing in Virginia Beachmaking wellness both effective and accessible
In the short-access (ShA) study, sessions lasted 1.5 h, while in the extended-access (ExA) study, sessions lasted 6 h
As the drug has skyrocketed in popularity, the investment community has taken notice, and rightfully so given the implications that a miracle weight loss drug could have on the market and society at large